Past administration of · -lactam antibiotics and increase in the emergence of · -lactamase-producing bacteria in patients with or ofacial odontogenic infections

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 89, Issue 2, 2000, Pages 186-192

  Kuriyama, Tomoari ^a   Nakagawa, Kiyomasa ^a   Karasawa, Tadahiro ^a   Saiki, Yasumasa ^a   Yamamoto, Etsuhide ^a   Nakamura, Shinichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM;

ABSCESS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHI SQUARE DISTRIBUTION; DRUG CONTRAINDICATION; DRUG EFFECT; ENZYMOLOGY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATIENT CARE PLANNING; PERIORAL DERMATITIS; TOOTH INFECTION;

ABSCESS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; CHI-SQUARE DISTRIBUTION; DERMATITIS, PERIORAL; FOCAL INFECTION, DENTAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PATIENT CARE PLANNING;

EID: 0034132617     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2000.102040     Document Type: Article

References (46)

1. Flynn TR. Odontogenic infections In: Laskin DM, Strauss RA, editors. Oral and maxillofacial surgery clinics of North America. Vol 3. Philadelphia: WB Saunders; 1991: p. 311-29.
2. Newman MG, Goodman AD. Oral and dental infections In: Finegold SM, George WL, editors. Anaerobic infections in human. San Diego: Academic Press; 1989. p. 233-61.
3. Gill Y, Scully C. Orofacial odontogenic infections review of microbiology and current treatment. Oral Surg Oral Med Oral Pathol 1990;70:155-8.
4. Sandor GK, Low DE, Judd PL, Davidson RJ. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc 1998;64:508-14.
5. Baker KA, Fotos PG. The management of odontogenic infections a rationale for appropriate chemotherapy. Dent Clin North Am 1994;38:689-706.
6. Moenning JE, Nelson CL, Kohler RB. The microbiology and chemotherapy of odontogenic infections. J Oral Maxillofac Surg 1989;47:976-85.
7. Nord CE. Mechanisms of · -lactam resistance in anaerobic bacteria. Rev Infect Dis 1986;8(Suppl 5):S543-S548.
8. Heimdahl A, von Konow L, Nord CE. Isolation of · -lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol 1980;25:689-92.
9. Neu HC. The emergence of bacterial resistance and its influence on empiric therapy. Rev Infect Dis 1983;5(Suppl):S9-S20.
10. Könönen E, Nyfors S, Mättö J. Asikainen S, Jousimies-Somer H. · -lactamase production by oral pigmented Prevotella species isolated from young children. Clin Infect Dis 1997;25(Suppl 2):S272-S274.
11. van Winkelhoff AJ, Winkel EG, Barendregt D, Dellemijn-Kippuw N, Stijne A, van der Velden U. · -lactamase producing bacteria in adult periodontitis. J Clin Periodontol 1997;24:538-43.
12. Jacobs MR, Spangler, SK, Appelbaum PC. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole. Eur J Clin Microbiol Infect Dis 1990;9:417-21.
13. Heimdahl A, von Konow L, Nord CE. · -lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J Antimicrob Chemother 1981;8:225-9.
14. Kinder SA, Holt SC, Korman KS. Penicillin resistance in the subgingival microbiota associated with adult periodontitis. J Clin Microbiol 1986;23:1127-33.
15. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr, editors Color atlas and textbook of diagnostic microbiology. 4th ed. Philadelphia: JB Lippincott; 1992. p. 519-607.
16. Lennett EH, Balows A, Hausler W Jr, Shadomy HJ, editors. Manual of clinical microbiology. 4th ed. Washington, DC: American Society of Microbiolog; 1985. p. 1-472.
17. Appelbaum PC, Spangler SK, Jacobs MR. · · lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother 1990;34:1546-50.
18. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 3rd ed. Approved standard. NCCLS document M11-A3. Villanova: National Committee for Clinical Laboratory Standards; 1993.
19. Japanese Society of Oral Therapeutics and Pharmacology, editor. [Dental drugs in Japan 1995]. Tokyo: Nippon Shika Yakuhin Kyogikai; 1995: p. 143-73. (Jpn).
20. Hecht DW, Malamy MH, Tally FP. Mechanisms of resistance and resistance transfer in anaerobic bacteria. In: Finegold SM, GeorgeWL, editors. Anaerobic infections in human. San Diego: Academic Press; 1989: p. 755-69.
21. Hackman AS, Wilkins TD. Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis on penicillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol 1976;21:385-9.
22. Lewis MAO, Parkhurst CL, Douglas CWI, Martin MV, Absi EG, Bishop PA, et al. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J Antimicrob Chemother 1995;35:785-91.
23. Brook I. Beta-lactamase-producing bacteria in head and neck infection. Laryngoscope 1988;98:428-31.
24. Lewis MAO, MacFarlane TW, McGowan DA. Quantitative bacteriology of acute dento-alveolar abscesses. J Med Microbiol 1986;21:101-4.
25. Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in anaerobes. Clin Infect Dis 1997;24(Suppl 1):S110-S120.
26. Wilson JT. Antimicrobial chemotherapy. In: Schuster GS, editor. Oral microbiology and infectious disease. 3rd ed. Philadelphia: BC Decker Inc; 1990: p. 176-91.
27. Neu HC. Contribution of beta-lactamase to bacterial resistance and mechanisms to inhibit beta-lactamase. Am J Med 1985;79(5B):2-12.
28. Thornsberry C. The development of antimicrobial resistance in staphylococci. J Antimicrob Chemother 1988;21(Suppl C):9-17.
29. Mandell GL, Petri WA Jr. Antimicrobial agents: penicillin, cephalosporins, and other · -lactam antibiotics. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman's the pharmacological basis of therapeutics 9th ed. New York: McGraw-Hill;1996: p. 1073-101.
30. Jones RN. Review of the in-vitro spectrum and characteri sties of cefmetazole (CS-1170). J Antimicrob Chemother 1989;23(Suppl D):1-12.
31. Schentag JJ. Cefmetazole sodium: pharmacology, pharmacokinetics, and clinical trials. Pharmacotherapy 1991;11:2-19.
32. Waxier HM, Finegold SM. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agentsagainst anaerobic bacteria. Antimicrob Agents Chemother 1988;32:403-6.
33. Wexler HM, Molitoris E, Finegold SM. Effect of · -lactamase inhibitors on the activities of various · -lactam agents against anaerobic bacteria. Antimicrob Agents Chemother 1991;35:1219-24.
34. Appelbaum PC, Spangler SK, Jacobs MR. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents. Antimicrob Agents Chemother 1991;35:1214-8.
35. Kropp H, Gerckens L, Sundelof JG, Kahan FM. Antibacterial activity of imipenem: the first thienamycin antibiotic. Rev Infect Dis 1985;7(Suppl 3):S389-S410.
36. Wexler HM, Finegold SM. In vitro activity of imipenem against anaerobic bacteria. Rev Infect Dis 1985;7(Suppl 3):S417-S425.
37. Brook I, Gober AE. Emergence of · -lactamase producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatr 1984;23:338-41.
38. Heimdahl A, Nord CE. Treatment of orofacial infections of odontogenic origin. Scand J Infect Dis Suppl 1985;46:101-5.
39. Styrt B, Gorbach SL. Recent developments in the understanding of the pathogenesis and treatment of anaerobic infections. N Eng J Med 1989;321:298-302.
40. Thompson RL. Cephalosporin, carbapenem, and monobactam antibiotics. Mayo Clin Proc 1987;62:821-34.
41. Brook I, Frazier EH, Gher ME. Aerobic and anaerobic microbiology of periapical abscess. Oral Microbiol Immunol 1991;6:123-5.
42. Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994;264:388-93.
43. Pallasch TJ. Antibiotics for acute orofacial infections. J Calif Dent Assoc 1993;21:34-44.
44. Jacobs JA, Stobberingh EE. In-vitro antimicrobial susceptibility of the Streptococcus milleri group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius). J Antimicrob Chemother 1996;37:371-5.
45. Fleming P, Feigal RJ, Kaplan EL, Liljemark WF, Little JW. The development of penicillin-resistant oral streptococci after repeated penicillin prophylaxis. Oral Surg Oral Med Oral Pathol 1990;70:440-4.
46. Finegold SM, Wexler HM. Present status of therapy for anaerobic infections. Clin Infect Dis 1996;23(Suppl 1):S9-S14.